The current state of knowledge of the immune ecosystem in alopecia areata
Authors:
- 10 February 2022
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 21 (5) , 103061
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32AI007485)
- National Institutes of Health (K08 AR069111)
- National Institutes of Health (R01 AR077194)
- U.S. Department of Veterans Affairs (I01 BX004907)
- University of Iowa (T32AI007485)
This publication has 156 references indexed in Scilit:
- Janus kinase inhibitors in autoimmune diseasesAnnals of the Rheumatic Diseases, 2013
- Increased Expression of Cxcr3 and Its Ligands, Cxcl9 and Cxcl10, during the Development of Alopecia Areata in the MouseJournal of Investigative Dermatology, 2012
- The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic useMicrobes and Infection, 2012
- Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areataEuropean Journal of Human Genetics, 2011
- CXCR3 in T cell functionExperimental Cell Research, 2011
- Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathologyJournal of Experimental Medicine, 2010
- Genome-wide association study in alopecia areata implicates both innate and adaptive immunityNature, 2010
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- New insights into the regulation of T cells by γc family cytokinesNature Reviews Immunology, 2009
- Role of Th1 and Th17 cells in organ-specific autoimmunityJournal of Autoimmunity, 2008